(74 days)
No
The summary describes a mechanical device with antimicrobial agents, and explicitly states "Mentions AI, DNN, or ML: Not Found".
No.
The device acts as an accessory for fluid administration and contains antimicrobial agents to reduce contamination, not to treat existing patient infections or provide therapy.
No
The device is described as an accessory for administering fluids and is designed to reduce microbial contamination, not to diagnose medical conditions.
No
The device description clearly states it is a physical connector made of plastic and silicone with antimicrobial agents compounded into these materials. It is a hardware device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's an accessory to an intravascular administration set for administering fluids to a patient through a cannula. This is a direct interaction with the patient's circulatory system for therapeutic purposes (fluid administration), not for examining specimens from the human body to provide information for diagnosis, monitoring, or compatibility testing.
- Device Description: The description focuses on the physical components and the antimicrobial agents' function within the device itself and the fluid path, not on analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing patient samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information.
Therefore, this device falls under the category of a medical device used for direct patient care and fluid administration, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Antimicrobial CLAVE® Connector is a single use, sterile, non-pyrogenic device intended for use as an accessory to an intravascular administration set for the administration of fluids to a patient through a cannulae placed in the vein or artery.
The connector includes two antimicrobial agents. The first agent is compounded with liquid silicone rubber to provide a protective seal around the cannula. The second agent is compounded with the polycarbonate alloy and is intended to reduce microbial contamination in the device fluid path. The antimicrobial agents are not intended for treating existing patient infections.
Product codes
FPA, LHI
Device Description
The ICU Medical Ag CLAVE is created with two different and effective antimicrobial agents. The first antimicrobial agent, compounded with the liquid silicone rubber (LSR), then molded into the plug that seals around and protects the first line of defense. The second antimicrobial agent, compounded with the plastics used to mold the cannula protects the fluid path from bacteria growth. Both the plug material and the cannula material are identical to the traditional CLA VE Connector as described in K970855 before the antimicrobial agents are compounded with them. Both the submitted and predicate CLA VE device are made up of three components; an internal plastic cannula (spike) which incorporates the fluid path, a plastic housing which allows for standardized ISO 594-1/2 luer lock connections and a silicone septum (plug) which provides the sealing mechanism and swabbing surface.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Efficacy and functional testing of the device are included in this submission. Additionally, the Antimicrobial CLAVE has been tested under the ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing. The results of that testing is included in this submission.
ICU Medical Antimicrobial CLA VE's are accessories and not a standalone device. Additionally, ICU Medical performs risk analysis and design verification testing based on pre-determined criteria published internally as a Performance Specification and based on ISO 14971. All tests meet the performance specification defined for the Antimicrobial CLAVE Connector. ICU Medical has also performed testing recommended by the draft guidance "Premarket Notification [5]0(k)] Submissions for Medical Devices that Include Antimicrobial Agents" and has included that testing as part of this submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
Image /page/0/Picture/0 description: The image shows the text "K090/89 1 of 2" at the top. Below the text is a logo of a horse. The text "ICU Medical, Inc." is located to the right of the horse logo.
ICU MEDICAL INC. 4455 Atherton Drive Salt Lake City, Utah (801) 264 - 1332, Phone (801) 264 - 1755, Fax Tracy S. Best, Sr. Regulatory Affairs Specialist Preparation Date: 04/09/2009
APR 1 0 2009
510(K) Summary of Safety and Effectiveness for the:
Trade Name: Antimicrobial CLA VE, Ag CLA VE®
Common Name: Needleless Connector, Needlefree Connector, Closed Access
21 CFR 880.5440, Class II Device, 80FPA and 80LHI, Accessory Classification Name:
Legally Marketed Predicate Devices for Substantial Equivalence:
- K970855 - CLAVE Connector - ICU Medical Inc. *K072576 & K081289 - V-Link™ Antimicrobial Luer Activated Device - Baxter Healthcare Corp
Rationale for SE:
The ICU Medical Antimicrobial CLAVE is equivalent to devices that provide a needleless connection with a closed system. The antimicrobial feature is substantially equivalent to those devices already approved as they release antimicrobial ionic silver. The components of the Antimicrobial CLAVE are molded from materials that are identical to or substantially equivalent to its predicate, the CLAVE Connector. The V-Link is a needleless connector as is the submitted device. Both the CLAVE and the V-Link have a proven history in the medical device market. While V-Link uses a silver coating, the ICU Medical Ag CLAVE components are compounded with the antimicrobial agents to prevent the agent from wearing off the components.
Description of Submitted Device:
The ICU Medical Ag CLA VE is created with two different and effective antimicrobial agents. The first antimicrobial agent, compounded with the liquid silicone rubber (LSR), then molded into the plug that seals around and protects the first line of defense. The second antimicrobial agent, compounded with the plastics used to mold the cannula protects the fluid path from bacteria growth. Both the plug material and the cannula material are identical to the traditional CLA VE Connector as described in K970855 before the antimicrobial agents are compounded with them. Both the submitted and predicate CLA VE device are made up of three components; an internal plastic cannula (spike) which incorporates the fluid path, a plastic housing which allows for standardized ISO 594-1/2 luer lock connections and a silicone septum (plug) which provides the sealing mechanism and swabbing surface.
Efficacy and functional testing of the device are included in this submission. Additionally, the Antimicrobial CLAVE has been tested under the ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing. The results of that testing is included in this submission.
1
Image /page/1/Picture/0 description: The image shows handwritten text. The text at the top reads "K090/189". Below that, the text reads "2 of 2". The handwriting is cursive and the text is written in black ink.
Intended Use of the Antimicrobial CLAVE:
The Antimicrobial CLAVE® Connector is a single use, sterile, non-pyrogenic device intended for use as an accessory to an intravascular administration set for the administration of fluids to a patient through a cannula placed in the vein or artery.
The connector includes two antimicrobial agents. The first agent is compounded with liquid silicone rubber to provide a protective seal around the cannula. The second agent is compounded with the polycarbonate alloy and is intended to reduce microbial contamination in the device fluid path. The antimicrobial agents are not intended for treating existing patient infections.
| Component: | ICU Medical Ag CLAVE | ICU Medical CLAVE
Connector | Baxter Healthcare
V-Link |
|-----------------------------------------|------------------------------------------------------------------------------------|--------------------------------|---------------------------------------------|
| Treated
components | 1. Liquid Silicone Rubber
2. Cannula/Spike/Fluid path | None | All surfaces of the
polycarbonate device |
| Antimicrobial
Agent
& application | 1. AM Agent Compounded -
LSR
2. AM Agent Compounded -
Polycarbonate Alloy | None
None | Antimicrobial
Coating |
| Sterilization
Method | Gamma or E-beam | Gamma or E-beam | Gamma |
| 510(k)
Approval | This submission | K970855 | K072576 and
K081289 |
Technological Characteristics and Substantial Equivalence Table:
The operational characteristics are identical to predicate devices for needleless luer connection.
Safety and Performance:
ICU Medical Antimicrobial CLA VE's are accessories and not a standalone device. Additionally, ICU Medical performs risk analysis and design verification testing based on pre-determined criteria published internally as a Performance Specification and based on ISO 14971. All tests meet the performance specification defined for the Antimicrobial CLAVE Connector.
ICU Medical has also performed testing recommended by the draft guidance "Premarket Notification [5]0(k)] Submissions for Medical Devices that Include Antimicrobial Agents" and has included that testing as part of this submission.
Conclusion:
The materials, performance, and operational features of both the submitted device and the predicate devices are substantially equivalent and are safe and effective for their intended use.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of a caduceus, a symbol often associated with medicine and healthcare.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Tracy Best Senior Regulatory Affairs Specialist ICU Medical, Incorporated 4455 Atherton Drive Salt Lake City, Utah 84123
APR 1 0 2009
Re: K090189 Trade/Device Name: Antimicrobial CLAVE Regulation Number: 21 CFR 880.5440 Regulatory Class: II Product Code: FPA, LHI
Dated: January 23, 2009 Received: January 26, 2009
Dear Mr. Best:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2- Mr. Best
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of Surveillance and Biometrics/Division of Postmarket Surveillance at 240-276-3464. For more information regarding the reporting of adverse events, please go to http://www.fda.gov/cdrh/mdr/.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Charmony 10. watson for
Susan Runner, D.D.S., MA Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K090189
Device Name: Antimicrobial CLAVE
Indications for Use:
The Antimicrobial CLAVE® Connector is a single use, sterile, non-pyrogenic device intended for use as an accessory to an intravascular administration set for the administration of fluids to a patient through a cannulae placed in the vein or artery.
The connector includes two antimicrobial agents. The first agent is compounded with liquid silicone rubber to provide a protective seal around the cannula. The second agent is compounded with the polycarbonate alloy and is intended to reduce microbial contamination in the device fluid path. The antimicrobial agents are not intended for treating existing patient infections.
Prescription Use _ XX (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Anta Om
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K090189